Acumen Pharmaceuticals, Inc. (ABOS) vs Fortress Biotech, Inc. (FBIOP)
A side-by-side comparison of Acumen Pharmaceuticals, Inc. and Fortress Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABOS
Acumen Pharmaceuticals, Inc.
$2.13HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
FBIOP
Fortress Biotech, Inc.
$18.10HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ABOS vs FBIOP
growth of $100 · dividends reinvested · last 5yABOS -89.4% (-36.2%/yr)FBIOP +0.3% (+0.1%/yr)FBIOP compounded faster over this window
Log scale — wide-divergence pair
ABOS FBIOP
ABOS vs FBIOP: by the numbers
- •ABOS is the larger company ($154M vs $142M market cap).
- •FBIOP is profitable (163.32% net margin) while ABOS runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ABOS | FBIOP |
|---|---|---|
| P/E ratio | N/A | 6.75 |
| Forward P/E | N/A | 7.10 |
| P/S ratio | N/A | 2.08 |
| P/B ratio | 2.69 | 0.87 |
| FCF yield | N/A | 88.32% |
Profitability
| Metric | ABOS | FBIOP |
|---|---|---|
| Gross margin | 0.00% | 62.53% |
| Operating margin | 0.00% | -111.00% |
| Net margin | 0.00% | 163.32% |
| ROE | -183.44% | 68.12% |
| ROIC | -118.67% | -10.85% |
Growth (annualized)
| Metric | ABOS | FBIOP |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 5.39% |
| Total return CAGR (5Y) | -32.60% | 0.05% |
Frequently asked
- Is ABOS or FBIOP more profitable?
- FBIOP runs the higher net margin — ABOS at 0.00% versus FBIOP at 163.32%.
- How have ABOS and FBIOP total returns compared?
- Over the past 5 years, ABOS delivered -32.60% and FBIOP delivered 0.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Fortress Biotech P/E ratioAcumen Pharmaceuticals ROEFortress Biotech ROEAcumen Pharmaceuticals operating marginFortress Biotech operating marginAcumen Pharmaceuticals revenue growthFortress Biotech revenue growthAcumen Pharmaceuticals free cash flowFortress Biotech free cash flow
Acumen Pharmaceuticals & Fortress Biotech appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.